SCHEMBL4187380

SCHEMBL4187380

Cc1nc2[nH]ncc2c2c(F)c(O)c(F)cc12

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SGK1 O00141 3/20 0.37
▸ TP53 P04637 3/20 0.34
▸ PLK4 O00444 4/20 0.34
▸ HTR2C P28335 3/20 0.34
▸ HTR2A P28223 2/20 0.34
▸ PAK4 O96013 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ RAF1 P04049 1/20 0.32
▸ BRAF P15056 1/20 0.32
▸ FGFR1 P11362 1/20 0.32
▸ FGFR2 P21802 1/20 0.32
▸ RPS6KA3 P51812 1/20 0.32
▸ VRK1 Q99986 1/20 0.32
▸ JAK2 O60674 2/20 0.32
▸ JAK1 P23458 2/20 0.32
▸ TYK2 P29597 2/20 0.32
▸ JAK3 P52333 2/20 0.32
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638970 0.80 FGFR1 (0.35) SGK1TP53PLK4HTR2CHTR2A
SCHEMBL24348512 0.70 HTR2C (0.39) SGK1PLK4HTR2CHTR2APAK4
SCHEMBL4199881 0.68 CYP1A2 (0.32) —
SCHEMBL4201049 0.67 TGFBR1 (0.32) TP53LMNAPOLB
SCHEMBL4196477 0.67 JAK2 (0.39) SGK1TP53LMNAFGFR1FGFR2
SCHEMBL24349703 0.67 ACHE (0.44) SGK1PLK4HTR2CHTR2APAK4
SCHEMBL30406140 0.67 HTR2C (0.37) SGK1PLK4HTR2CHTR2APAK4
SCHEMBL24348566 0.67 HTR2C (0.37) SGK1PLK4HTR2CHTR2APAK4
SCHEMBL30536612 0.66 FGFR1 (0.39) PLK4RAF1BRAFFGFR1FGFR2
Hydrochloric Acid SCHEMBL4200853 0.66 JAK2 (0.32) SGK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648455-A4 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS INC (US) 2009-03-04 — — EP disclosed
EP-1648455-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-04-26 — — EP disclosed
WO-2005009389-A2 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-02-03 — — WO disclosed
Send feedback